World Health Organization site
Skip Navigation Links

Main
Note: This record shows only the 20 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: REBEC
Last refreshed on: 29 April 2013
Main ID:  RBR-9fwv27
Date of registration: 04/01/2012
Primary sponsor: Faculdade de Ciência e Tecnologia - Universidade Estadual Paulista - Brazil
Public title: Study of gait and balance of subjects suffering from diabetic foot complications.
Scientific title: Gait parameters, plantar pressures and body balance of diabetics with neuropathy and vasculopathy that use insoles
Date of first enrolment: 10/11/2011
Target sample size: 40
Recruitment status: not yet recruiting
URL:  http://www.ensaiosclinicos.gov.br/rg/RBR-9fwv27/
Study type: 
Study design:  Clinical trial,factorial, controlled non-random, open.  
Countries of recruitment
Brazil
Contacts
Name: Alessandra   Mantovani
Address:  Avenida Rui Barbosa, 203 19560000 Indiana Brazil
Telephone: (18) 39951590
Email: leka_indy@hotmail.com
Affiliation:  Faculdade de Ciência e Tecnologia - Universidade Estadual Paulista
Name: Cristina Elena  Fregonesi
Address:  Rua Roberto Simonsen, 305 19060900 Presidente Prudente Brazil
Telephone: (18) 3229 5555
Email: cristina@fct.unesp.br
Affiliation:  Faculdade de Ciência e Tecnologia - Universidade Estadual Paulista
Key inclusion & exclusion criteria
Inclusion criteria: In the diabetic group, will need medical confirmation of diabetes mellitus, changes in the circulation and peripheral perfusion, detected respectively by the ankle/ brachial index and pulse oximetry, and diabetic neuropathy confirmed by insensitivity to the Semmes-Weinstein monofilament 10g and the scale for the diagnosis of diabetic distal polyneuropathy. For the control group, it is mandatory sensitivity to monofilament 2g, confirming the normality of somatosensory sensitivity of the feet.
Exclusion criteria: Will be excluded from the study who were diagnosed with other neurological disease or neuropathic; to have visual impairment or vestibular important and uncorrected, inability to understand for testing.

Age minimum: 55Y
Age maximum: 70Y
Gender: -
Health Condition(s) or Problem(s) studied
Subjects suffering from diabetic neuropathic and vascular complications in the feet.
C10.668.829.300
Intervention(s)
Initially all methodological procedures will be performed for two groups: control (CG) and diabetic (GD), followed by periodic reassessments of the GD, ending with a comparison of data.
Stage I - At this stage all subjects in both groups (GC and GD) will be submitted to the methodological procedures of the study (detection of vasculopathy and neuropathy, plantar pressure analysis of static and dynamic equilibrium analysis).
Stage II - The GD participants will receive customized insoles and will be reviewed at regular intervals: a) one minute after placing the insole b) two days after use; c) fifteen days after use; d) thirty days of use, and Finally, e) forty-five days of use. So, you can show, within forty-five days, how long it takes to act effectively insole (if effective) and prolonged use causes hipercorreções or, ultimately, see if this time the gains and losses arising from the use insole follow, or not, temporal rules.
The frequency of use of the insole will be at least five days a week and eight hours a day, comfortable shoes pre-assessed by the researcher. The subject will receive control chips to record the use of insoles.
Primary Outcome(s)
In the phase of data management will be comparing the results obtained in all evaluations of Phase II with data from the Phase I of GD (to test whether the subjects showed improvement on its initial situation) and GC (to observe if, by the use of insoles, reached values ??closer to those obtained in the GC).
The statistical analysis consists of, initially to check the distribution as to normality by the Shapiro-Wilk. Comparisons between different time points (before use of sock = T1, one minute after placing the insole (T2), two days after its use = T3; after fifteen days of use = T4; thirty days of use = T5, and Finally, forty-five days of use = T6) will be done using analysis of variance for repeated measures, supplemented by post-hoc Tukey. In this study, analysis of covariance (ANCOVA) will also be used for the same comparisons, but using the body mass, height, gender, speed, leg length and duration of disease as covariates. All tests will be performed using the SPSS 17.0 software and the level of significance is 5%.
We hope to find more abnormal gait, body balance and plantar pressure points on the feet of the individual components of the DG compared to CG.
Secondary Outcome(s)
Still, we seek to propose an effective tool in the prevention of ulcers and amputation in the diabetic population.
We believe that with the use of insoles, better distribution of plantar pressure, decrease in body movements and better performance on spatial-temporal parameters of gait.
Secondary ID(s)
10/2011
Source(s) of Monetary Support
Faculdade de Ciência e Tecnologia - Universidade Estadual Paulista - Brazil
Secondary Sponsor(s)
Faculdade de Ciência e Tecnologia - Universidade Estadual Paulista - Brazil
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.1 - Version history